SUBSCRIBE
SUBSCRIBE
News   FDA

FzioMed Inc.'s Oxiplex Gel for Spine Surgery Approved in Canada

February 29, 2008 | 
1 min read
SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--FzioMed, Inc. (www.fziomed.com) today announced that Health Canada has approved the company’s Oxiplex® gel for use in lumbar spine surgery.
FDA Approvals
MORE ON THIS TOPIC
halftone magazine style banner, dislike, negative rating, hand thumbs down
Complete response letters
Fortress, Sentynl Fail To Secure FDA Nod in Rare Pediatric Disease
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Government
US Government Shuts Down, FDA Closed for New Applications
October 1, 2025
 · 
4 min read
 · 
Annalee Armstrong
Marburg, Germany - July 6, 2013: Marburg Office of Swiss multinational company Novartis AG
Approvals
Novartis Secures First FDA Approval of Oral BTK Inhibitor for Chronic Hives
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA CDER director George Tidmarsh speaking in an FDA video
Regulatory
FDA’s Tidmarsh Singles Out Aurinia’s Drug in LinkedIn Post About Surrogate Endpoints
September 30, 2025
 · 
2 min read
 · 
Tristan Manalac